Insights into HIV-1 capsid inhibitors in preclinical and early clinical development as antiretroviral agents

Cevik, Muge; Orkin, Chloe

View/Open

Capsidinhibitors_v3_26Oct_clean.pdf (347.3Kb)

Date

18/11/2019

Altmetrics Handle Statistics

Altmetrics DOI Statistics

Citation

Cevik , M & Orkin , C 2019 , ' Insights into HIV-1 capsid inhibitors in preclinical and early clinical development as antiretroviral agents ' , Expert Opinion on Investigational Drugs , vol. Latest Articles , pp. 1-4 . https://doi.org/10.1080/13543784.2019.1692811

Publication

Expert Opinion on Investigational Drugs

Status

Peer reviewed

DOI

https://doi.org/10.1080/13543784.2019.1692811

ISSN

1354-3784

Type

Journal item

Rights

Copyright © 2019 Informa UK Limited, trading as Taylor & Francis Group. This work has been made available online in accordance with publisher policies or with permission. Permission for further reuse of this content should be sought from the publisher or the rights holder. This is the author created accepted manuscript following peer review and may differ slightly from the final published version. The final published version of this work is available at https://doi.org/10.1080/13543784.2019.1692811

Collections

University of St Andrews Research

URI

http://hdl.handle.net/10023/21001